AT378183B - Verfahren zur herstellung von neuen quaternaeren piperidinium-verbindungen - Google Patents

Verfahren zur herstellung von neuen quaternaeren piperidinium-verbindungen

Info

Publication number
AT378183B
AT378183B AT0900782A AT900782A AT378183B AT 378183 B AT378183 B AT 378183B AT 0900782 A AT0900782 A AT 0900782A AT 900782 A AT900782 A AT 900782A AT 378183 B AT378183 B AT 378183B
Authority
AT
Austria
Prior art keywords
quaternaire
piperidinium
connections
producing new
producing
Prior art date
Application number
AT0900782A
Other languages
English (en)
Other versions
ATA900782A (de
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ATA900782A publication Critical patent/ATA900782A/de
Application granted granted Critical
Publication of AT378183B publication Critical patent/AT378183B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0900782A 1981-01-28 1982-01-27 Verfahren zur herstellung von neuen quaternaeren piperidinium-verbindungen AT378183B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/229,244 US4321386A (en) 1981-01-28 1981-01-28 Quaternary piperidinium halides
PCT/US1982/000108 WO1982002551A1 (en) 1981-01-28 1982-01-27 Quaternary piperidinium halides

Publications (2)

Publication Number Publication Date
ATA900782A ATA900782A (de) 1984-11-15
AT378183B true AT378183B (de) 1985-06-25

Family

ID=22860396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0900782A AT378183B (de) 1981-01-28 1982-01-27 Verfahren zur herstellung von neuen quaternaeren piperidinium-verbindungen

Country Status (19)

Country Link
US (1) US4321386A (de)
JP (1) JPH0348904B2 (de)
AR (1) AR230266A1 (de)
AT (1) AT378183B (de)
AU (1) AU551523B2 (de)
BE (1) BE891938A (de)
CA (1) CA1184917A (de)
CH (1) CH651021A5 (de)
DE (1) DE3223499T1 (de)
DK (1) DK156649C (de)
FI (1) FI65239C (de)
GB (1) GB2100736B (de)
GR (1) GR74720B (de)
IE (1) IE52420B1 (de)
IT (1) IT1147809B (de)
NL (1) NL8220049A (de)
SE (1) SE435057B (de)
WO (1) WO1982002551A1 (de)
YU (1) YU43063B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010118055A1 (en) * 2009-04-09 2010-10-14 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
EP2458983B1 (de) 2009-07-31 2015-07-08 Cognition Therapeutics, Inc. Hemmer des kognitiven abbaus
JP2014511373A (ja) 2011-02-02 2014-05-15 コグニション セラピューティクス インク. ウコン油から単離された化合物およびその使用方法
EP4023294A1 (de) 2014-01-31 2022-07-06 Cognition Therapeutics, Inc. Isoindolinzusammensetzungen und verfahren zur behandlung der alzheimer-krankheit
BR112019023851A2 (pt) 2017-05-15 2020-08-18 Cognition Therapeutics, Inc. compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037910A (en) * 1958-04-18 1962-06-05 Burroughs Wellcome Co Process for treatment of hypertension
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917679A (en) * 1974-04-12 1975-11-04 Lilly Co Eli Quaternary ammonium salts of N-dialkylaminoalkyl-N-(2-indanyl)anilines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037910A (en) * 1958-04-18 1962-06-05 Burroughs Wellcome Co Process for treatment of hypertension
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF MEDICINAL CHEMISTRY BD. 16, NO. 9, 1973, SEITEN 1015-1020 *
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, BD. 200, NO. 1, 1977, J. E. BYRNE ET AL,SEITEN 147-154 *

Also Published As

Publication number Publication date
SE8205535D0 (sv) 1982-09-28
DK429382A (da) 1982-09-27
JPH0348904B2 (de) 1991-07-25
GR74720B (de) 1984-07-10
IT1147809B (it) 1986-11-26
SE435057B (sv) 1984-09-03
AU8148582A (en) 1982-08-16
DK156649B (da) 1989-09-18
IE820191L (en) 1982-07-28
GB2100736B (en) 1985-01-30
FI65239C (fi) 1984-04-10
IT8247667A0 (it) 1982-01-28
FI65239B (fi) 1983-12-30
DK156649C (da) 1990-02-05
FI822443L (fi) 1982-07-08
JPS57502216A (de) 1982-12-16
FI822443A0 (fi) 1982-07-08
YU19782A (en) 1985-04-30
AR230266A1 (es) 1984-03-01
GB2100736A (en) 1983-01-06
AU551523B2 (en) 1986-05-01
DE3223499C2 (de) 1989-11-23
CH651021A5 (de) 1985-08-30
SE8205535L (sv) 1982-09-28
IE52420B1 (en) 1987-10-28
DE3223499T1 (de) 1983-01-13
CA1184917A (en) 1985-04-02
BE891938A (fr) 1982-07-28
US4321386A (en) 1982-03-23
WO1982002551A1 (en) 1982-08-05
NL8220049A (nl) 1982-11-01
YU43063B (en) 1989-02-28
ATA900782A (de) 1984-11-15

Similar Documents

Publication Publication Date Title
AT377524B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT382612B (de) Verfahren zur herstellung von neuen arylcyclobutylalkylaminen
AT384017B (de) Verfahren zur herstellung von neuen hydroxyaminoestern
ATA125383A (de) Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen
ATA206483A (de) Verfahren zur herstellung von neuen mitosanderivaten
AT382638B (de) Verfahren zur herstellung von neuen trehaloselipiden
AT381091B (de) Verfahren zur herstellung von neuen ergolinderivaten
ATA5985A (de) Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen
AT386199B (de) Verfahren zur herstellung von neuen 2-piperazinopyrimidinen
AT375943B (de) Verfahren zur herstellung von neuen mitosanverbindungen
AT386828B (de) Verfahren zur herstellung von neuen acylaminomitosanen
AT380683B (de) Verfahren zur herstellung von neuen diaminophenolaethern
AT380477B (de) Verfahren zur herstellung von neuen spirothiazolidindion-derivaten
AT376222B (de) Verfahren zur herstellung von neuen azinorifamycinverbindungen
AT378183B (de) Verfahren zur herstellung von neuen quaternaeren piperidinium-verbindungen
AT376679B (de) Verfahren zur herstellung von neuen bisindolalkaloiden
AT384214B (de) Verfahren zur herstellung von neuen mercaptoacylcarnitinen
AT381318B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT377264B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT386408B (de) Verfahren zur herstellung von neuen thioalkanoyl- carnitinen
AT373231B (de) Verfahren zur herstellung von neuen alkoxyalkanoyl-carnitinhydrohalogeniden
ATA52285A (de) Verfahren zur herstellung von neuen diazepinoindolen
AT381939B (de) Verfahren zur herstellung von neuen azaspiroalkandionen
ATA354581A (de) Verfahren zur herstellung von neuen 11-hydroxy-13 -oxa-postaglandinderivaten
AT378776B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden